// June 08, 2023
Insights from India: Q&A with USP nitrosamines expert
The issue of addressing potential nitrosamine impurities in medicines has been the focus at event
The issue of addressing potential nitrosamine impurities in medicines has been the focus at event
Another public health crisis looms in the wake of the COVID-19 pandemic.
With significant innovations in pharmaceuticals, including biologic drugs
Access to medicines is a complicated topic.